VIVIGEN REPORTS PROFITVivigen Inc. (NASDAQ:VIVI) of Santa Fe, N.M., reported a $1.17million profit on revenues of $11.4 million in fiscal 1990.

Year ended Dec. 31

(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 11,412 9,080 +26Net income 1,173 1,636 -28Net income per share .45 .64 -30

MEDCO RESEARCH REPORTS MODEST PROFIT

Medco Research Inc. (NASDAQ:MEDR) of Los Angeles attributedits first profitable quarter to Fujisawa USA Inc.'s marketing ofMedco's Adenocard for the treatment of paroxysmalsupraventricular tachycardia.

First quarter ended Nov. 30

(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 466 38 +1126Net income (loss) 22 (177) n.a.Net income per share (loss) negl. (.02) n.a.Outstanding shares 8,669 8,610 negl.

(c) 1997 American Health Consultants. All rights reserved.

No Comments